Sudeep Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|
| Revenue | 99.72 | 100.71 | 86.79 |
| Operating Expense | 60.67 | 57 | 49.78 |
| Net Profit | 26.87 | 29.74 | 25.20 |
| Net Profit Margin | 26.95 | 29.53 | 29.04 |
| Earning Per Share | 2.42 | 2.67 | 2.29 |
| EBIDTA | 38.56 | 43.22 | 36.59 |
| Effective Tax Rate | 23.74 | 22.15 | 22.16 |
| Particulars | Dec 2025 |
|---|---|
| Revenue | 99.72 |
| Operating Expense | 60.67 |
| Net Profit | 26.87 |
| Net Profit Margin | 26.95 |
| Earning Per Share | 2.42 |
| EBIDTA | 38.56 |
| Effective Tax Rate | 23.74 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 356.73 | 343.76 | 404.00 |
| Operating Expenses Annual | 224.77 | 211.54 | 315.73 |
| Operating Profit Annual | 140.33 | 140.42 | 99.44 |
| Interest Annual | 4.81 | 2.97 | 3.84 |
| Depreciation | 6.03 | 5.06 | 4.74 |
| Net Profit Annual | 95.75 | 98.08 | 67.17 |
| Tax Annual | 33.66 | 34.23 | 23.60 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 356.73 |
| Operating Expenses Annual | 224.77 |
| Operating Profit Annual | 140.33 |
| Interest Annual | 4.81 |
| Depreciation | 6.03 |
| Net Profit Annual | 95.75 |
| Tax Annual | 33.66 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 8.59 | 6.35 | 14.87 |
| Cash Flow from Operations | 59.15 | 59.05 | 42.31 |
| Cash Flow from Investing | -91.59 | -40.67 | -40.71 |
| Cash Flow from Financing | 54.20 | -16.14 | -10.11 |
| Cash Flow at the End | 30.35 | 8.59 | 6.35 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 8.59 |
| Cash Flow from Operations | 59.15 |
| Cash Flow from Investing | -91.59 |
| Cash Flow from Financing | 54.20 |
| Cash Flow at the End | 30.35 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 39.58 | 41.06 | 24.86 |
| PBIT Margin (%) | 37.87 | 39.56 | 23.66 |
| PBT Margin (%) | 31.20 | 28.81 | 18.76 |
| Net PROFIT Margin (%) | 26.84 | 28.53 | 16.63 |
| Return On Networth / Equity (%) | 25.12 | 34.32 | 33.16 |
| Return On Networth /Employed (%) | 28.51 | 38.66 | 34.81 |
| Return On Assets (%) | 20.13 | 27.96 | 24.44 |
| Total Debt / Equity (X) | 0.24 | 0.23 | 0.35 |
| Asset Turnover Ratio (%) | 0.75 | 0.98 | 1.47 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 39.58 |
| PBIT Margin (%) | 37.87 |
| PBT Margin (%) | 31.20 |
| Net PROFIT Margin (%) | 26.84 |
| Return On Networth / Equity (%) | 25.12 |
| Return On Networth /Employed (%) | 28.51 |
| Return On Assets (%) | 20.13 |
| Total Debt / Equity (X) | 0.24 |
| Asset Turnover Ratio (%) | 0.75 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 105.27 | 95.88 | 89.82 |
| Total Current Assets Annual | 313.02 | 230.75 | 235.85 |
| Non Current Assets Annual | 291.08 | 219.85 | 180.17 |
| Total Shareholders Funds Annual | 430.12 | 334.60 | 236.88 |
| Total Assets Annual | 604.10 | 450.60 | 416.03 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 105.27 |
| Total Current Assets Annual | 313.02 |
| Non Current Assets Annual | 291.08 |
| Total Shareholders Funds Annual | 430.12 |
| Total Assets Annual | 604.10 |
EPS (INR)
Expected
4.20
Reported
4.29
Surprise
2.14%
Sep 2025
EPS beaten by 2.14%
Jun 2025
EPS beaten by -10.83%
Mar 2025
EPS beaten by -10.41%
